cp wire

CP Wire Articles

The company plans to offer 4,333,333 American Depositary Shares and raise a maximum $79,733,328. Bicycle has applied to trade trade on the NASDAQ Global Market under the symbol "BCYC."

... read more

Tue, 05/14/19 - 09:23 am
admin
Fri, 05/10/19 - 09:44 am
admin
Advances in oral insulin development bring promise of a better lifestyle for millions of Americans who rely on daily insulin injections 
 
New York, NY, May 9... read more
Thu, 05/9/19 - 01:03 pm
admin

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria,... read more

Tue, 05/7/19 - 11:28 pm
admin

Twist Bioscience (NASDAQ: TWIST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced on 5/6/19 that it has commenced... read more

Tue, 05/7/19 - 09:36 am
admin

Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, announced on 4/30/19 that data demonstrating its... read more

Thu, 05/2/19 - 11:51 am
admin

Triumvira, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, has simultaneously submitted an IND to the U.S. Food and Drug... read more

Wed, 05/1/19 - 09:54 am
admin

Clinical-stage biopharmaceutical company, NextCure, has updated its filing for an IPO to raise up to $93 million. The company has applied to trade on NASDAQ under the symbol, "NXTC”.

... read more

Mon, 04/29/19 - 09:57 am
admin

AOBiome Featured in Bloomberg Businessweek
It was a snowy week in February 2009 when David Whitlock packed up... read more

Fri, 04/26/19 - 11:14 am
admin

Sirnaomics Inc. announced on 4/26/19 that it has sealed the C2 round of financing for $22 million. This round of funding was led by CR-CP Life Sciences Fund, a Hong Kong based joint venture... read more

Fri, 04/26/19 - 10:01 am
admin

Clinical-stage biopharma, Applied Therapeutics, updated the filing for its upcoming IPO. The company will raise up to $86 million. It intends to trade under the symbol, "APLT", on NASDAQ.

... read more

Thu, 04/25/19 - 09:42 am
admin

On 4/22/19, Gritstone Oncology filed for a $102 Million offering of its common stock. Gritstone trades on NASDAQ under the symbol, “GRTS.” The company currently has a market cap of $394 Million.... read more

Tue, 04/23/19 - 09:45 am
admin

On 4/22/19, TransMedics updated their filing for an IPO to raise up to $91 million. The commercial stage company has developed an organ transplant support system for heart, lung and liver... read more

Mon, 04/22/19 - 10:08 am
admin

Clinical stage biopharmaceutical company, Trevi Therapeutics, updated their filing for an IPO to raise up to $74 million. Trevi is focused on the development and commercialization of nalbuphine ER... read more

Mon, 04/22/19 - 09:49 am
admin

On 4/17/19 KCI Holdings filed for a $100 million IPO. KCI is a leading medical technology company focused on advanced wound care and specialty surgical applications. The initial filing did not... read more

Thu, 04/18/19 - 10:00 am
admin

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ:  EVGN) (TASE: EVGN), announced on 4/17/19 the... read more

Wed, 04/17/19 - 09:44 am
admin

 On 4/16/19, Flagship Pioneering,  unveiled Kintai Therapeutics and named Paul-Peter Tak, M.D., Ph.D., as president, chief executive officer, and member of the board of directors. Kintai is... read more

Tue, 04/16/19 - 09:54 am
admin

Cortexyme has filed for an $86 million IPO. The company is developing treatments for neurodegenerative diseases based on the discovery of pathogenic bacteria in the brains of Alzheimer's patients... read more

Mon, 04/15/19 - 09:56 am
admin

Pages


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.